beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16982753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Strategies of Tumor Immune Evasion

  2012cited by this paper
• Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by β‐carotene via activation of cAMP, PKA, CREB and ERK1/2

  2006cited by this paper
• Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development

  2006cited by this paper
• A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

  2005cited by this paper
• Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway.

  2005cited by this paper
• Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.

  2005cited by this paper
• Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.

  2005cited by this paper
• Endothelin receptor antagonists

  2005cited by this paper
• The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.

  2005cited by this paper
• Molecular requirements for epithelial-mesenchymal transition during tumor progression.

  2005cited by this paper
• Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.

  2005cited by this paper
• Prostate carcinoma cells that have resided in bone have an upregulated IGF‐I axis

  2004cited by this paper
• Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.

  2004cited by this paper
• RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.

  2004cited by this paper
• Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.

  2004cited by this paper
• A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression

  2004cited by this paper
• The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia.

  2002cited by this paper
• Systemic tumor suppression by the proapoptotic gene bik.

  2002cited by this paper
• Metastatic prostate carcinoma to bone

  2002cited by this paper
• Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Changes in beta-2 microglobulin expression in prostate cancer.

  2000cited by this paper
• Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR.

  2000cited by this paper
• LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis

  2000cited by this paper
• Bone sialoprotein.

  1999cited by this paper
• Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

  1999cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.

  1998cited by this paper
• Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

  1998cited by this paper
• CORRELATION BETWEEN TUMOUR AND SERUM β2m EXPRESSION IN PATIENTS WITH BREAST CANCER

  1996cited by this paper
• Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.

  1995cited by this paper
• A Novel Promoter for Vascular Endothelial Growth Factor Receptor (flt-1) That Confers Endothelial-specific Gene Expression (*)

  1995cited by this paper
• The Interaction between Beta 2‐Microglobulin (ßm) and Purified Class‐I Major Histocompatibility (MHC) Antigen

  1994cited by this paper
• Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.

  1992cited by this paper
• Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

  1991cited by this paper
• Immunoreactivity and proliferative actions of beta 2 microglobulin on human bone-derived cells in vitro.

  1991cited by this paper
• Beta 2-microglobulin enhances insulin-like growth factor I receptor levels and synthesis in bone cell cultures.

  1989cited by this paper
• The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.

  1987cited by this paper
• Osteocalcin: the vitamin K-dependent Ca2+-binding protein of bone matrix.

  1986cited by this paper
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

  1986cited by this paper
• The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens.

  1986cited by this paper
• Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells

  1984cited by this paper
• Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

  1983cited by this paper
• [The plasma concentration of beta 2-microglobulin in the diagnosis of malignancy of the gastrointestinal tract (author's transl)].

  1979cited by this paper
• Obligatory Transformation of Fibroblasts by Bone Matrix in Rats Fed Sucrose Ration 1

  1974cited by this paper
• The complete amino acid sequence of beta 2-microglobulin.

  1973cited by this paper
• Sequence determination.

  1970cited by this paper

• Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney Function

  2025cites this paper
• Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients

  2025cites this paper
• β2-microglobulin induced apoptosis of tumor cells via the ERK signaling pathway by directly interacting with HFE in HER2-overexpressing breast cancer

  2024cites this paper
• Clinical Challenges in Prostate Cancer Management: Metastatic Bone-tropism and The Role of Circulating Tumor Cells.

  2024cites this paper
• The Role of Beta2-Microglobulin in Central Nervous System Disease

  2024cites this paper
• Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study

  2024cites this paper
• Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma

  2024cites this paper
• The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients

  2024cites this paper
• Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors

  2023cites this paper
• Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

  2023cites this paper
• β2-microglobulin and colorectal cancer among inpatients: a case–control study

  2023cites this paper
• Liquid–Liquid Phase Separation of Biomacromolecules and Its Roles in Metabolic Diseases

  2022cites this paper
• Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis

  2022cites this paper
• Investigation of proteomic profiles in canine lymphoma using tandem mass tag-based quantitative proteomics approach

  2022cites this paper
• Research Advances in the Relationship between Serum Markers and the Prognosis of Diffuse Large B-Cell Lymphoma

  2022cites this paper
• β2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages.

  2022cites this paper
• Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis

  2022cites this paper
• β2-microglobulin is overexpressed in buccal cells of elderly and correlated with expression of p16 and inflammatory genes

  2022cites this paper
• Studies of hormonal regulation, phenotype plasticity, bone metastasis, and experimental therapeutics in androgen-repressed human prostate cancer (ARCaP) model.

  2021influential citation
• Beta 2 microglobulin correlates with oxidative stress in elderly.

  2021cites this paper
• EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling

  2021cites this paper
• B2M overexpression correlates with malignancy and immune signatures in human gliomas

  2021cites this paper
• Primary Gastric Diffuse Large B-Cell Lymphoma: Prognostic Factors in the Immuno-Oncology Therapeutics Era

  2020cites this paper
• Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

  2019cites this paper
• Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells

  2019cites this paper
• β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER− breast cancer with HER2−

  2019cites this paper
• PAK4 signaling in health and disease: defining the PAK4–CREB axis

  2019cites this paper
• Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.

  2019cites this paper
• Novel prognostic scoring system for diffuse large B-cell lymphoma.

  2018cites this paper
• Exploring the preventive effect of physical activity on prostate cancer-induced testicular dysfunction

  2018cites this paper
• Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial–Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells

  2018cites this paper
• Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.

  2018cites this paper
• MiRNA 34a: a therapeutic target for castration-resistant prostate cancer

  2016cites this paper
• Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence

  2016cites this paper
• Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients

  2016cites this paper
• The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator

  2016cites this paper
• Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)

  2016cites this paper
• Loss of HLA class I expression in prostate cancer and restoration using adenoviral and adeno-associated viral vectors

  2016cites this paper
• A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.

  2015cites this paper
• Dickkopf-3 (DKK-3) obstructs VEGFR-2/Akt/mTOR signaling cascade by interacting of β2-microglobulin (β2M) in ovarian tumorigenesis.

  2015cites this paper
• Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

  2015cites this paper
• Anti-β 2 -microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy

  2015cites this paper
• Antigenic Hsp70–peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton’s lymphoma bearing mice

  2015cites this paper
• Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition

  2014cites this paper
• miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer

  2014cites this paper
• Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture

  2014cites this paper
• Biology of Human Tumors miR-154 and miR-379 in the DLK 1-DIO 3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer

  2014cites this paper
• RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization

  2014cites this paper
• β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy

  2014influential citation
• Characterization of β2-microglobulin expression in different types of breast cancer

  2014cites this paper
• Anti‐β2M monoclonal antibodies kill myeloma cells via cell‐ and complement‐mediated cytotoxicity

  2014cites this paper
• Beta-2-microglobulin gene transfer in hla class i deficient tumor cells using recombinant adenovirus

  2014cites this paper
• RANK-mediated signaling network and cancer metastasis

  2014cites this paper
• Inhibition of β2-Microglobulin/Hemochromatosis Enhances Radiation Sensitivity by Induction of Iron Overload in Prostate Cancer Cells

  2013cites this paper
• [Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options].

  2013cites this paper
• Monoclonal Antibodies Directed Against Chicken β2-Microglobulin Developed With a Synthesized Peptide

  2013cites this paper
• Towards a vaccine to prevent cancer in Lynch syndrome patients

  2013cites this paper
• Correlation of serum β2-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer.

  2013cites this paper
• The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases

  2013cites this paper
• Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek’s disease viral infections

  2013cites this paper
• Decipher β2-microglobulin: Gain- or loss-of-function (a mini-review)

  2013cites this paper
• MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells

  2013cites this paper
• Future perspectives of prostate cancer therapy

  2012cites this paper
• Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer

  2012cites this paper
• Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

  2012cites this paper
• iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer

  2012cites this paper
• Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma

  2012cites this paper
• Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

  2012cites this paper
• Serum ò2-Microglobulin Levels in Patients with Various Solid Cancer

  2012cites this paper
• Targeting cell surface β2‐microglobulin by pentameric IgM antibodies

  2011influential citation
• β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

  2011cites this paper
• From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis

  2011cites this paper
• Molecular and Cellular Pathobiology b 2-Microglobulin Induces Epithelial to Mesenchymal Transition and Confers Cancer Lethality and Bone Metastasis in Human Cancer Cells

  2011cites this paper
• b 2-Microglobulin Induces Epithelial to Mesenchymal Transition and Confers Cancer Lethality and Bone Metastasis in Human Cancer Cells

  2011cites this paper
• Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma

  2011cites this paper
• Killing tumor cells through their surface β2‐microglobulin or major histocompatibility complex class I molecules

  2010cites this paper
• Tumor-stroma co-evolution in prostate cancer progression and metastasis.

  2010cites this paper
• Beta‐2‐microglobulin expression correlates with high‐grade prostate cancer and specific defects in androgen signaling

  2010cites this paper
• Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells*

  2010cites this paper
• β2-Microglobulin as a potential factor for the expansion of mesenchymal stem cells

  2009cites this paper
• Novel Immunotherapies

  2009cites this paper
• The Prostate 69 : 949 ^ 955 ( 2009 ) Soluble FactorsDerived FromStromaActivated AndrogenReceptor Phosphorylation inHuman Prostate LNCaPCells : Roles of ERK / MAPKinase

  2009cites this paper
• Award Number: W81XWH-07-1-0172 TITLE: Beta 2-Microglobulin: A Novel Therapeutic Target for the Treatment of Human Prostate Cancer Bone Metastasis

  2009cites this paper
• Modified Human Beta 2‐Microglobulin (desLys58) Displays Decreased Affinity for the Heavy Chain of MHC Class I and Induces Nitric Oxide Production and Apoptosis

  2009cites this paper
• Serum Soluble Interleukin‐2 Receptor, Beta2‐Microglobulin, Lactate Dehydrogenase and Erythrocyte Sedimentation Rate in Children with Hodgkin’s Lymphoma

  2009cites this paper
• Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells.

  2009cites this paper
• Identification of beta2-microglobulin as a potential target for ovarian cancer

  2009cites this paper
• Novel antigenic targets for immunotherapy in myeloma

  2009cites this paper
• Beta2-microglobulin: emerging as a promising cancer therapeutic target.

  2009cites this paper
• Differential expression of osteocalcin during the metastatic progression of prostate cancer.

  2009cites this paper
• Radiation modulation of MicroRNA in prostate cancer cell lines

  2008cites this paper
• The Prostate 68 : 1599 ^ 1606 ( 2008 ) RadiationModulationofMicroRNAinProstateCancer Cell Lines

  2008cites this paper
• The Production of Designed Potential Protein Contrast Agents and their Encapsulation in Albumin Microspheres

  2008cites this paper
• Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model

  2008cites this paper
• Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion

  2008cites this paper
• β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells

  2008cites this paper
• Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone

  2008cites this paper
• Critical and Distinct Roles of p16 and Telomerase in Regulating the Proliferative Life Span of Normal Human Prostate Epithelial Progenitor Cells*

  2008cites this paper
• Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.

  2007cites this paper
• Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.

  2007cites this paper